Regulators Target Diabetes Drug Metformin for NDMA Contamination By Sam | January 13, 2020 Healthcare regulators have set their sights on type 2 diabetes drug metformin to see if it contains unsafe amounts of N-nitrosodimethylamine (NDMA). Source: Drug GMP Report Posted in Drug GMP Report